Jul 21, 2019
Ascentage Pharma to Initiate Phase Ib Study of HQP1351 in Tyrosine Kinase Inhibitors -resistant Chronic Myeloid Leukemia Patients in the US
Jul 08, 2019
Adempas (Riociguat; Bayer/Merck & Co) Drug Overview & Product Profiles 2016-2025
Jul 01, 2019
Global Aliqopa (Copanlisib; Bayer) Drug Profile 2019: A Small Molecule Phosphoinositide 3-Kinase (PI3K) Inhibitor with High Selectivity for the p110-alpha/delta Catalytic Subunits
Jun 27, 2019
Letairis (ambrisentan; Gilead/GlaxoSmithKline) Market to 2025: A Selective Endothelin Type A Receptor Antagonist
Jun 26, 2019
Opsumit Drug Profile 2016-2025: Opsumit (macitentan; Johnson & Johnson/Nippon Shinyaku) is Set to Become the Market Leader with Forecast Peak Sales of $2.2bn in 2025
Jun 26, 2019
Tracleer (bosentan; Johnson & Johnson) Drug Overview & Product Profiles 2016-2025
Jun 25, 2019
Global Myelofibrosis Market 2017-2018 & 2019-2026: Celgene's $1.1bn Impact Buy is First of More Deals to Come in 2018 and Beyond
Jun 21, 2019
Fursultiamine (CAS 804-30-8) Market Research Report 2019 - ResearchAndMarkets.com
Jun 19, 2019
World Endometriosis Markets, 2014-2019 & 2019-2026: Key Pipeline and Marketed Drugs, Clinical Trials, Upcoming and Regulatory Events, Patent Information, Licensing and Acquisition Deals
Jun 19, 2019
Global Pulmonary Arterial Hypertension Market 2018-2025: Label Expansions Beyond PAH and Evidence Championing Polypharmacy Drive Market Expansion, with Opsumit and Uptravi Leading
Jun 13, 2019
Rigel to Present Two Posters Highlighting Fostamatinib at the 24 Congress of the European Hematology Association (EHA)
Jun 11, 2019
Extensive Analyses of Phase 3 Data for Investigational Lemborexant Assess Efficacy and Safety Profile for the Potential Treatment of Insomnia in Adults
Jun 04, 2019
Sierra Announces FDA Regulatory Clarity for Momelotinib & Design of the MOMENTUM Phase 3 Clinical Trial
Jun 01, 2019
Blueprint Medicines Presents NAVIGATOR Trial Data in PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST at ASCO 2019 Supporting Planned Marketing Applications for Avapritinib
May 29, 2019
Bayer Receives U.S. FDA Breakthrough Therapy Designation for Aliqopa(TM) (copanlisib) for the Treatment of Marginal Zone Lymphoma
May 28, 2019
Sierra Oncology to Present Momelotinib and SRA737 Overview at the Jefferies Global Healthcare Conference in New York
May 28, 2019
Eisai to Present Eight Lemborexant Posters at SLEEP 2019 Meeting, Including New Pooled Analyses From Phase 3 Studies and New Phase 1 Data
May 14, 2019
Roivant Statement on Positive Phase 3 Results from Myovant's LIBERTY 1 Study in Uterine Fibroids
Apr 30, 2019
Eisai and Purdue Pharma Announce Buy Out of Purdue's Rights in Worldwide Collaboration to Develop and Commercialize Lemborexant
Apr 08, 2019
Armas Pharmaceuticals Expands Generic Portfolio with Launches of Capecitabine and Imatinib